Anadys Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anadys Pharmaceuticals, Inc..The latest application filed is for "5,6-dihydro-1h-pyridin-2-one compounds".

Company Profile

0.44.56

Anadys Pharmaceuticals, Inc. - South San Francisco CA US
Anadys Pharmaceuticals, Inc. - San Diego CA US
Anadys Pharmaceuticals Inc. -
Anadys Pharmaceuticals, Inc - San Diego CA
Anadys Pharmaceuticals, Inc. - 3115 Merryfield Row San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Method of preparing deoxyribofuranose compounds Grant 9,227,992 - Haley January 5, 2	2016-01-05
Dosing methods for treating disease Grant 9,161,946 - Appleman , et al. October 20, 2	2015-10-20
5,6-dihydro-1H-pyridin-2-one compounds Grant 9,156,832 - Dragovich , et al. October 13, 2	2015-10-13
5,6-dihydro-1h-pyridin-2-one Compounds App 20150065492 - Dragovich; Peter ; et al.	2015-03-05
Method Of Preparing Deoxyribofuranose Compounds App 20140350231 - Haley; Gregory J.	2014-11-27
3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof Grant 8,883,758 - Webber , et al. November 11, 2	2014-11-11
Method of preparing deoxyribofuranose compounds Grant 8,829,168 - Haley September 9, 2	2014-09-09
[1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid Grant 8,815,847 - Freddo August 26, 2	2014-08-26
5,6-dihydro-1H-pyridin-2-one compounds Grant 8,765,741 - Dragovich July 1, 2	2014-07-01
Dosing Methods For Treating Disease App 20140094427 - Appleman; James ; et al.	2014-04-03
Method Of Inhibiting Hepatitus C Virus By Combination Of A 5,6-dihydro-1h-pyridin-2-one And One Or More Additional Antiviral Compounds App 20140066396 - Dragovich; Peter S. ; et al.	2014-03-06
5,6-dihydro-1h-pyridin-2-one Compounds App 20140031346 - Tran; Chinh V. ; et al.	2014-01-30
Deuterated 5,6-dihydro-1H-pyridin-2-one compounds Grant 8,586,578 - Webber November 19, 2	2013-11-19
3,5-Disubstituted and 3,5,7-Trisubstituted-3H-Oxazolo and 3H-Thiazolo[4,5-d]pyrimidin-2-one Compounds and Prodrugs Thereof App 20130259831 - Webber; Stephen E. ; et al.	2013-10-03
5,6-D hydro-1H-pyridin-2-one compounds Grant 8,546,602 - Tran , et al. October 1, 2	2013-10-01
Semi-continuous And Continuous Enzymatic Hydrolysis Process App 20130137143 - Gallou; Fabrice ; et al.	2013-05-30
Bridged Polycyclic Compounds App 20120321590 - Webber; Stephen E. ; et al.	2012-12-20
[1,2,4]thiadiazine 1,1-dioxide Compounds For Lowering Serum Uric Acid App 20120316156 - Freddo; James L.	2012-12-13
5,6-dihydro-1h-pyridin-2-one Compounds App 20120302744 - Tran; Chinh V. ; et al.	2012-11-29
Deuterated 5,6-dihydro-1h-pyridin-2-one Compounds App 20120283251 - Webber; Stephen E.	2012-11-08
5,6-dihydro-1H-pyridin-2-one compounds Grant 8,236,948 - Tran , et al. August 7, 2	2012-08-07
[1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound Grant 8,222,404 - Dragovich , et al. July 17, 2	2012-07-17
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 8,211,863 - Averett July 3, 2	2012-07-03
Method for preparing furanose compounds Grant 8,193,342 - Kucera , et al. June 5, 2	2012-06-05
5,6-dihydro-1h-pyridin-2-one Compounds App 20120130068 - Tran; Chinh V. ; et al.	2012-05-24
3,5-disubstituted And 3,5,7-trisubstituted-3h-oxazolo And 3h-thiazolo[4,5-d]pyrimidin-2-one Compounds And Prodrugs Thereof App 20120121541 - Webber; Stephen E. ; et al.	2012-05-17
[1,2,4]thiadiazin-3-yl Acetic Acid Compound[[s]] And Methods Of Making The Acetic Acid Compound App 20120116077 - Ruebsam; Frank ; et al.	2012-05-10
5,6-dihydro-1H-pyridin-2-one compounds Grant 8,129,368 - Ruebsam , et al. March 6, 2	2012-03-06
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20120028999 - Averett; Devron R.	2012-02-02
5,6-dihydro-1H-pyridin-2-one compounds Grant 8,101,800 - Tran , et al. January 24, 2	2012-01-24
3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof Grant 8,097,718 - Webber , et al. January 17, 2	2012-01-17
[1,2,4]thiadiazine 1,1-dioxide compounds Grant 8,097,613 - Ruebsam , et al. January 17, 2	2012-01-17
Method Of Preparing Deoxyribofuranose Compounds App 20110288282 - Haley; Gregory J.	2011-11-24
3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF App 20110275589 - Webber; Stephen E. ; et al.	2011-11-10
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 8,034,802 - Averett October 11, 2	2011-10-11
Method Of Inhibiting Hepatitus C Virus By Combination Of A 5,6-dihydro-1h-pyridin-2-one And One Or More Additional Antiviral Compounds App 20110229438 - Dragovich; Peter ; et al.	2011-09-22
Method For Preparing Furanose Compounds App 20110172447 - Kucera; David ; et al.	2011-07-14
Dosing Methods For Treating Disease App 20110166092 - Appleman; James ; et al.	2011-07-07
5,6-dihydro-1h-pyridin-2-one Compounds App 20110166344 - Tran; Chinh V. ; et al.	2011-07-07
3-.beta.-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof Grant 7,943,759 - Averett , et al. May 17, 2	2011-05-17
5,6-dihydro-1H-pyridin-2-one compounds Grant 7,939,524 - Tran , et al. May 10, 2	2011-05-10
P-toluene sulfonic acid salt of 5-amino-3-(2'-O-acetyl-3'-deoxy-.beta.-D-ribofuranosyl)-3H-thiazole[4,5-d- ]pyrimidine-2-one and methods for preparation Grant 7,928,085 - Kucera , et al. April 19, 2	2011-04-19
Pyrro[1,2-b]pyridazinone intermediates Grant 7,842,838 - Webber , et al. November 30, 2	2010-11-30
4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds Grant 7,834,009 - Ellis , et al. November 16, 2	2010-11-16
5-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] Pyrimidin-2-oce Salts And Crystalline Forms App 20100286081 - Mutz; Michael ; et al.	2010-11-11
3- -D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF App 20100261667 - Averett; Devron R. ; et al.	2010-10-14
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20100256169 - Averett; Devron R.	2010-10-07
Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one Grant 7,781,581 - Wang , et al. August 24, 2	2010-08-24
3-.beta.-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof Grant 7,745,415 - Averett , et al. June 29, 2	2010-06-29
5,6-dihydro-1h-pyridin-2-one Compounds App 20100119481 - Ruebsam; Frank ; et al.	2010-05-13
Prodrugs of 5-amino-3-(3'-deoxy-.beta.-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-- dione Grant 7,709,448 - Haley , et al. May 4, 2	2010-05-04
5,6-dihydro-1h-pyridin-2-one Compounds App 20100034773 - Tran; Chinh V. ; et al.	2010-02-11
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS App 20090312570 - Webber; Stephen E. ; et al.	2009-12-17
[1,2,4]thiadiazine 1,1-dioxide Compounds App 20090306057 - Ruebsam; Frank ; et al.	2009-12-10
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20090298863 - Averett; Devron R.	2009-12-03
Pyrro[1,2-b]pyridazinone compounds Grant 7,582,754 - Webber , et al. September 1, 2	2009-09-01
5,6-dihydro-1H-pyridin-2-one compounds Grant 7,582,626 - Tran , et al. September 1, 2	2009-09-01
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 7,576,068 - Averett August 18, 2	2009-08-18
P-Toluene Sulfonic Acid Salt of 5-Amino-3-(2'-O-Acetyl-3'-Deoxy-Beta-D-Ribofuranosyl)-3H-Thiazole[4,5-d]p- yrimidine-2-one and Methods for Preparation App 20090197826 - Kucera; David ; et al.	2009-08-06
3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof Grant 7,560,544 - Webber , et al. July 14, 2	2009-07-14
Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines Grant 7,528,115 - Haley , et al. May 5, 2	2009-05-05
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS App 20090105473 - Webber; Stephen E. ; et al.	2009-04-23
Pyrro[1,2-b]pyridazinone compounds Grant 7,462,611 - Ruebsam , et al. December 9, 2	2008-12-09
1-methyl-benzo[1,2,4]thiadiazine 1-oxide Derivatives App 20080292588 - Zhou; Yuefen ; et al.	2008-11-27
3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF App 20080255063 - Averet; Devron R. ; et al.	2008-10-16
Pyridazinone compounds Grant 7,425,552 - Zhou , et al. September 16, 2	2008-09-16
Pyridazinone Compounds App 20080188466 - Dragovich; Peter ; et al.	2008-08-07
Pyridazinone Compounds App 20080090814 - Ellis; David ; et al.	2008-04-17
3-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereof App 20080090844 - Averett; Devron R. ; et al.	2008-04-17
Prodrugs of 5-amino-3-(3'-deoxy-b-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione App 20080032999 - Haley; Gregory J. ; et al.	2008-02-07
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS App 20080031852 - Webber; Stephen E. ; et al.	2008-02-07
CARBONATE AND CARBAMATE PRODRUGS OF THIAZOLO[4,5-d]PYRIMIDINES App 20080020989 - Haley; Gregory J. ; et al.	2008-01-24
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof Grant 7,321,033 - Averett , et al. January 22, 2	2008-01-22
Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds App 20070197533 - Zhou; Yuefen ; et al.	2007-08-23
Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds Grant 7,223,759 - Zhou , et al. May 29, 2	2007-05-29
Novel process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one App 20070117979 - Wang; Tingman ; et al.	2007-05-24
Pyridazinone compounds App 20060189602 - Zhou; Yuefen ; et al.	2006-08-24
3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof App 20060160830 - Webber; Stephen E. ; et al.	2006-07-20
Hepatitis C virus constructs characterized by high efficiency replication App 20050260221 - Bichko, Vadim ; et al.	2005-11-24
3-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof App 20050182001 - Averett, Devron R. ; et al.	2005-08-18
Hepatitis C virus constructs characterized by high efficiency replication Grant 6,930,095 - Bichko August 16, 2	2005-08-16
3-.beta.-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof Grant 6,924,271 - Averett , et al. August 2, 2	2005-08-02
Heterocyclic compounds for treating hepatitis C virus App 20050075375 - Vourloumis, Dionisios ; et al.	2005-04-07
3-B-D-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof App 20050070556 - Averett, Devron R. ; et al.	2005-03-31
Hepatitis C virus constructs characterized by high efficiency replication App 20040005549 - Bichko, Vadim ; et al.	2004-01-08
Translation driver system and methods for use thereof Grant 6,610,508 - Hentze , et al. August 26, 2	2003-08-26
Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids Grant 6,569,628 - Laing , et al. May 27, 2	2003-05-27
Antifungal compounds and methods of use App 20030027243 - Thompson, Craig ; et al.	2003-02-06
Screen for compounds with affinity for nucleic acids Grant 6,503,721 - Arenas , et al. January 7, 2	2003-01-07
Hepatitis C virus constructs characterized by high efficiency replication App 20020155133 - Bichko, Vadim	2002-10-24
Screen for compounds with affinity for nucleic acids App 20020064793 - Arenas, Jaime E. ; et al.	2002-05-30
Screening method for identifying ligands for target proteins App 20020055123 - Pakula, Andrew ; et al.	2002-05-09
Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids App 20020031778 - Laing, Lance G. ; et al.	2002-03-14

Company Registrations

NCAGE Code	4GL48	ANADYS PHARMACEUTICALS, INC.
CAGE Code	4GL48	ANADYS PHARMACEUTICALS, INC.
SEC	0001128495	ANADYS PHARMACEUTICALS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.